8/13/2014 11:17:43 AM
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals’ fast-growing portfolio of approved generic drugs is expanding once again with the launch of four new medications. Representing multiple therapeutic categories, these products accounted for $900 million annually in U.S. sales as of June 2014, according to IMS Health market data.
Acyclovir ointment, USP is available in 5% strength. Sold in 30-gram tubes, each gram of ointment contains 50 mg of acyclovir. The Amneal generic is an AB-rated therapeutic equivalent to Zovirax® Ointment 5%.
Help employers find you! Check out all the jobs and post your resume.
comments powered by